Cardinal Health ( (CAH) ) has released its Q4 earnings. Here is a breakdown of the information Cardinal Health presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cardinal Health is a global distributor of pharmaceuticals and medical products, operating in the healthcare sector with a focus on providing innovative solutions to improve healthcare delivery. The company is known for its extensive distribution network and commitment to enhancing patient care through its diverse range of services.
In its latest earnings report, Cardinal Health announced a relatively stable fourth-quarter revenue of $60.2 billion, with a notable 21% increase when excluding the impact of a contract expiration. The company also reported a significant rise in non-GAAP operating earnings and EPS, reflecting strong operational performance across its segments.
Key financial highlights include a 19% increase in non-GAAP operating earnings to $719 million and a 13% rise in non-GAAP diluted EPS to $2.08 for the fourth quarter. For the fiscal year 2025, adjusted free cash flow was reported at $2.5 billion. The company also raised its fiscal year 2026 non-GAAP EPS guidance to a range of $9.30 to $9.50, indicating confidence in future growth. Additionally, Cardinal Health announced the acquisition of Solaris Health, enhancing its position in the urology sector.
The Pharmaceutical and Specialty Solutions segment saw a profit increase of 11% in the fourth quarter, driven by acquisitions and sales growth. The Global Medical Products and Distribution segment experienced a 49% profit rise, attributed to volume growth. The ‘Other’ segment also reported a 44% profit increase, fueled by growth in at-Home Solutions and other areas.
Looking ahead, Cardinal Health’s management expresses confidence in continued growth, supported by strategic acquisitions and a robust financial outlook. The company aims to leverage its operational strengths and investments to achieve its long-term goals, as reflected in the raised guidance for fiscal year 2026.